David P Wilson
Overview
Explore the profile of David P Wilson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
237
Citations
3873
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Beltrame J, Wilson D
J Pharmacol Exp Ther
. 2024 Aug;
390(3):277-279.
PMID: 39159975
No abstract available.
2.
Killion J, Magana C, Cepeda J, Vo A, Hernandez M, Cyr C, et al.
AIDS
. 2023 Sep;
37(15):2389-2397.
PMID: 37773035
Background: Needle and syringe programs (NSPs) are effective at preventing HIV and hepatitis C virus (HCV) among people who inject drugs (PWID), yet global coverage is low, partly because governments...
3.
Kelly S, Abou Jaoude G, Palmer T, Skordis J, Haghparast-Bidgoli H, Gosce L, et al.
PLOS Glob Public Health
. 2023 Jun;
3(6):e0001025.
PMID: 37343015
High rates of drug-resistant tuberculosis (DR-TB) continue to threaten public health, especially in Eastern Europe. Costs for treating DR-TB are substantially higher than treating drug-susceptible TB, and higher yet if...
4.
Marques P, Wand H, Nandy M, Tan C, Shou H, Terplan M, et al.
FEMS Microbes
. 2023 Jun;
3:xtac004.
PMID: 37332497
We previously observed that the nine-member family of autotransported polymorphic membrane proteins (Pmps) of is variably expressed in cell culture. Additionally, -infected patients display variable Pmp-specific serum antibody profiles indirectly...
5.
Houdroge F, Palmer A, Delport D, Walsh T, Kelly S, Hainsworth S, et al.
Sci Rep
. 2023 Jan;
13(1):1398.
PMID: 36697434
Between June and August 2020, an agent-based model was used to project rates of COVID-19 infection incidence and cases diagnosed as positive from 15 September to 31 October 2020 for...
6.
Stuart R, Fraser-Hurt N, Shubber Z, Vu L, Cheik N, Kerr C, et al.
Health Policy Plan
. 2022 Nov;
38(1):122-128.
PMID: 36398991
Despite the push towards evidence-based health policy, decisions about how to allocate health resources are all too often made on the basis of political forces or a continuation of the...
7.
Ten Brink D, Martin-Hughes R, Minnery M, Osborne A, Schmidt H, Dalal S, et al.
PLoS One
. 2022 May;
17(5):e0268240.
PMID: 35617169
Introduction: More than 70% of new HIV infections in Asia occurred in eight countries in 2020: Cambodia, China, India, Indonesia, Myanmar, Nepal, Thailand, and Vietnam-with a rising incidence among men...
8.
Fraser-Hurt N, Hou X, Wilkinson T, Duran D, Abou Jaoude G, Skordis J, et al.
PLoS One
. 2021 Nov;
16(11):e0260247.
PMID: 34843546
Background: Countries are increasingly defining health benefits packages (HBPs) as a way of progressing towards Universal Health Coverage (UHC). Resources for health are commonly constrained, so it is imperative to...
9.
Wilson D, Roof D
Viruses
. 2021 Nov;
13(11).
PMID: 34834999
We introduce Viral Phrenology, a new scheme for understanding the genomic composition of spherical viruses based on the locations of their structural protrusions. We used icosahedral point arrays to classify...
10.
Gosce L, Abou Jaoude G, Kedziora D, Benedikt C, Hussain A, Jarvis S, et al.
PLoS Comput Biol
. 2021 Sep;
17(9):e1009255.
PMID: 34570767
Approximately 85% of tuberculosis (TB) related deaths occur in low- and middle-income countries where health resources are scarce. Effective priority setting is required to maximise the impact of limited budgets....